Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC). This is a virtual meeting open to the public, limited by the capacity of the conference webinar which is 2,000 participants. Pre-registration is required by accessing the link at: https://dceproductions.zoom.us/ webinar/register/WN_vCTciAdyQIeDK5g3NfFPow. There will be a public comment period from 2:15 p.m. to 4:15 p.m., EDT. The public is encouraged to register to provide public comment using the registration form available at the link provided in the meeting information section below.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 106 (Friday, June 4, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 106 (Friday, June 4, 2021)]
[Notices]
[Pages 30048-30049]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-11771]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
is a virtual meeting open to the public, limited by the capacity of the
conference webinar which is 2,000 participants. Pre-registration is
required by accessing the link at: <a href="https://dceproductions.zoom.us/webinar/register/WN_vCTciAdyQIeDK5g3NfFPow">https://dceproductions.zoom.us/webinar/register/WN_vCTciAdyQIeDK5g3NfFPow</a>. There will be a public
comment period from 2:15 p.m. to 4:15 p.m., EDT. The public is
encouraged to register to provide public comment using the registration
form available at the link provided in the meeting information section
below.
DATES: The meeting will be held on July 16, 2021, from 10:00 a.m. to
4:50 p.m., EDT.
ADDRESSES: Zoom Virtual Meeting. If you would like to attend the
virtual meeting, please pre-register by accessing the link at: <a href="https://dceproductions.zoom.us/webinar/register/WN_vCTciAdyQIeDK5g3NfFPow">https://dceproductions.zoom.us/webinar/register/WN_vCTciAdyQIeDK5g3NfFPow</a>.
Instructions to access the Zoom virtual meeting will be provided in the
link following your registration.
Meeting Information: There will be a public comment period from
2:15 p.m. to 4:15 p.m., EDT. The public is encouraged to register to
provide public comment using the registration form
[[Page 30049]]
available at the link provided: <a href="https://www.surveymonkey.com/r/zgbg7qz">https://www.surveymonkey.com/r/zgbg7qz</a>.
Individuals wishing to pre-register for public comment must do so
by 5:00 p.m., EDT, Monday, July 12, 2021. Those pre-registering for
public comment must also register for the meeting by accessing the link
at: <a href="https://dceproductions.zoom.us/webinar/register/WN_vCTciAdyQIeDK5g3NfFPow">https://dceproductions.zoom.us/webinar/register/WN_vCTciAdyQIeDK5g3NfFPow</a>. Individuals registered to provide public
comment will be called upon first to speak based on the order of
registration, followed by others from the public. All public comments
will be limited to two (2) minutes per speaker.
Written comments must be received on or before July 23, 2021;
<a href="/cdn-cgi/l/email-protection#2d434e445d4e4f5e4e6d4e494e034a425b"><span class="__cf_email__" data-cfemail="a0cec3c9d0c3c2d3c3e0c3c4c38ec7cfd6">[email protected]</span></a>. All written comments will be included as part of the
meeting minutes.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop S-1069, Atlanta, GA 30341-3717, Telephone:
(770) 488-1430; Email: <a href="/cdn-cgi/l/email-protection#dfb1bcb6afbcbdacbc9fbcbbbcf1b8b0a9"><span class="__cf_email__" data-cfemail="cca2afa5bcafaebfaf8cafa8afe2aba3ba">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. In addition, the Board provides advice on the
appropriate balance of intramural and extramural research, the
structure, progress, and performance of intramural programs. The Board
is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grants, cooperative agreements, and contracts
applications received in response to the funding opportunity
announcements as it relates to the Center's programmatic balance and
mission; (3) submission of secondary review recommendations to the
Center Director of applications to be considered for funding support;
(4) review of research portfolios; and (5) review of program proposals.
Matters To Be Considered: The agenda will include an update on the
process and progress of the draft Guideline for Prescribing Opioids and
discussion on the report from the BSC Opioid workgroup. Agenda items
are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-11771 Filed 6-3-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.